Creating and Leveraging Community Partnerships That Last
Drug Topics
MAY 12, 2023
Sometimes, paid advertising isn’t the best way to get the word out.
Fri.May 12, 2023
469 
Novel Treatment Achieves Up to 14.9% Weight Loss After 46 Weeks
Pharmacy Times
MAY 12, 2023
BI 456906 activates the GLP-1 and glucagon receptors that help to control metabolic function, and could potentially offer clinically relevant benefits for those living with obesity or overweight without type 2 diabetes.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
RPHCast, Episode One: Statins, Bloood Pressure, and Curves Galore
Drug Topics
MAY 12, 2023
Listen to the first episode of RPHCast, where Kevin and Donna educate you on all things statins, blood pressure, cholesterol, and as many curves as you can imagine.
FDA Approves Brexpiprazole for Agitation Associated With Dementia Related to Alzheimer Disease
Pharmacy Times
MAY 12, 2023
Brexpiprazole was associated with a statistically and clinically meaningful improvement in agitative behaviors caused by dementia compared to placebo.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
How Health Care Systems Are Working to Improve DEI Efforts
Drug Topics
MAY 12, 2023
Research shows that patient experiences and sometimes outcomes are improved when they are treated by health care professions from similar communities.
FDA Ends Ban on Blood Donations From Gay, Bisexual Men
Pharmacy Times
MAY 12, 2023
A new FDA policy would assess blood donor eligibility using a set of individual risk-based questions to reduce the risk of transfusion-transmitted HIV.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Atogepant Significantly Reduced Migraine Days in Patients With Prior Treatment Failure
Pharmacy Times
MAY 12, 2023
Atogepant reduced mean monthly migraine days by more than 2 days compared to placebo in the ELEVATE trial.
AI Tracking Can Increase Drug Delivery Efficiency for Specialty Pharmacies
Drug Topics
MAY 12, 2023
Parcel tracking technology that used predictive analytics can help with real-time package delivery monitoring and ensure on-time delivery.
Parents More Likely to Vaccinate Children Against COVID-19 After Talking to Trusted Parent
Pharmacy Times
MAY 12, 2023
Investigators found that providing parents with a hypothetical scenario outlining why they should immunize their children against COVID-19 was effective in improving vaccination rates.
Payers More Likely to Prefer Multiple Biosimilars for the Same Reference Product, Survey Finds
Drug Topics
MAY 12, 2023
88% of surveyed payers said interchangeability will have the biggest impact on adoption.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Multidisciplinary Teams in Medically Integrated Pharmacies Can Improve Personalized Care
Pharmacy Times
MAY 12, 2023
With a growing expectation for individualized and personalized care, medically integrated pharmacies have a great opportunity to support patients and the care team.
Major Trends in the 2023 Specialty Therapy Pipeline
Drug Topics
MAY 12, 2023
The specialty drug pipeline is projected to grow by 8% each year through 2025.
Help Patients Choose Appropriate Treatments to Survive Allergy Season
Pharmacy Times
MAY 12, 2023
Nonprescription products manage mild to moderate symptoms, but more severe cases need further medical evaluation.
In Order to Maintain the Industry, the Status Quo for Biosimilars Needs to Change
Drug Topics
MAY 12, 2023
Juliana Reed, executive director of the Biosimilars Forum, discussed the impact of market dynamics and changing pricing structures during a presentation at the 2023 Asembia Specialty Pharmacy Summit.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Million-dollar claims on the rise in self-insured employer plans: report
Fierce Healthcare
MAY 12, 2023
Million-dollar claims on the rise in self-insured employer plans: report fdiamond Fri, 05/12/2023 - 15:45
Addressing Current Challenges Women Face in the Health Care System
Drug Topics
MAY 12, 2023
Discussions around women’s health should extend beyond talking about menstruation and pregnancy to include all aspects of health.
Belong.Life, creator of a global social network for cancer patients, launches AI oncology mentor to support care
Fierce Healthcare
MAY 12, 2023
Belong.
FDA Approves Fezolinetant, A Novel Therapy for Vasomotor Symptoms in Menopause
Drug Topics
MAY 12, 2023
Vasomotor symptoms include hot flashes and night sweats, which can negatively impact a woman's quality of life.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Tracking the FDA advisory panel on Sarepta’s gene therapy for Duchenne muscular dystrophy
STAT
MAY 12, 2023
The Food and Drug Administration is convening a meeting of outside experts on Friday to review clinical data on an experimental gene therapy for Duchenne muscular dystrophy from Sarepta Therapeutics. The stakes for this all-day meeting are high and deliberations could be contentious. The advisory panel meeting is one of the most pivotal moments in recent memory for Duchenne patients and their families, many of whom view Sarepta’s gene therapy as the best hope for slowing the fatal muscle-
Alzheimer's drug lecanemab could boost Medicare spending by $5B a year: study
Fierce Healthcare
MAY 12, 2023
Alzheimer's drug lecanemab could boost Medicare spending by $5B a year: study fdiamond Fri, 05/12/2023 - 13:17
NACDS honors pharmacists, pharmacy team members in TV ad
Drug Store News
MAY 12, 2023
Timed with the formal end of the COVID-19 public health emergency on May 11, an NACDS ad is punctuating the occasion with a “thank you” to pharmacists and pharmacy teams.
$1.7b acquisition to develop rare haematology therapy
European Pharmaceutical Review
MAY 12, 2023
Swedish Orphan Biovitrum AB (Sobi ® ) has agreed to acquire CTI BioPharma for $1.7 billion, with the intention to advance an oral kinase inhibitor treatment for the rare disease myelofibrosis. Innovative therapies for rare diseases The acquisition will help to drive the growth of CTI’s lead product, kinase inhibitor VONJO ® (pacritinib) “in treating myeloproliferative disease,” stated Dr Adam Craig, President, Chief Executive Officer and Interim Chief Medical Officer of CTI BioPharma
Telehealth is here to stay, survey shows. How should the industry adapt?
Fierce Pharma
MAY 12, 2023
Telehealth is here to stay, survey shows. How should the industry adapt?
Ocean Spray, Hershey offer chocolate dipped cranberry snacks
Drug Store News
MAY 12, 2023
New launches include milk chocolate dipped cranberry bites and dark chocolate dipped cherry-infused cranberry bites.
STAT+: Up and down the ladder: The latest comings and goings
STAT
MAY 12, 2023
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.
As pharma fights IRA, Senate moves forward basket of bills aimed at lower drug prices
Fierce Pharma
MAY 12, 2023
As pharma fights IRA, Senate moves forward basket of bills aimed at lower drug prices aliu Fri, 05/12/2023 - 10:48
AI algorithm ‘could improve heart attack diagnosis’
pharmaphorum
MAY 12, 2023
AI algorithm ‘could improve heart attack diagnosis’ Phil.
A physician’s Mother’s Day gift: reclaimed time with my children — and for myself
STAT
MAY 12, 2023
As a child, I fondly remember running through the kids’ aisle at Video World with my younger brother. We were excited to pick out VHS tapes for our family to watch over the weekend. I don’t recall whether this was every weekend or once a month, but movie nights were frequent enough that they made up for my parents’ repeated absences in those years.
Colon cancer increasing in younger adults, new research warns
Drug Store News
MAY 12, 2023
Patients may have symptoms for a long time before seeking medical attention or receiving a colon cancer diagnosis, which is treatable if discovered early.
STAT+: FDA advisory panel narrowly recommends approval for Sarepta’s gene therapy for Duchenne
STAT
MAY 12, 2023
For an archived version of a live blog about Friday’s FDA advisory panel hearing, click here. A panel of independent advisers to the Food and Drug Administration narrowly voted 8-6 to recommend accelerated approval for Sarepta’s gene therapy for Duchenne muscular dystrophy , ruling that the potential benefit to patients outweighs a long list of concerns from the agency’s reviewers.
Takeda reports 12.8% rise in FY2022 revenue
Pharmaceutical Technology
MAY 12, 2023
Takeda has reported a 12.8% increase in its reported revenue to $29.96bn (Y4,027bn) during the fiscal year 2022 (FY2022) compared to that reported in FY2021. At a constant exchange rate (CER), the company’s core revenue grew by 3.5% compared to the previous year. In the FY2022 ending 31 March 2023, the company also reported a 6.4% rise in its operating profit to $3.65bn (Y490.5bn) compared to 2021.
Meijer opens new supercenter in Elkhart
Drug Store News
MAY 12, 2023
Meijer has opened its 11th one-stop shopping experience in Northern Indiana.
Could personalised mRNA vaccine be first for cancer?
European Pharmaceutical Review
MAY 12, 2023
A BioNTech-led Phase I trial demonstrated preliminary evidence that adjuvant autogene cevumeran, a personalised mRNA neoantigen vaccine, in combination with atezolizumab (Genentech) and mFOLFIRINOX can induce substantial T cell activity in pancreatic ductal adenocarcinoma (PDAC). In a paper published in Nature , researchers hypothesised it may correlate with delayed recurrence and elimination of micrometastases in PDAC.
Let's personalize your content